Published online Oct 27, 2023. doi: 10.4240/wjgs.v15.i10.2331
Peer-review started: July 9, 2023
First decision: August 10, 2023
Revised: August 14, 2023
Accepted: August 21, 2023
Article in press: August 21, 2023
Published online: October 27, 2023
Processing time: 110 Days and 1.6 Hours
Obesity, with varying global definitions due to body fat disparities between Western and Asian populations, elevates colorectal cancer risk by 7% to 60%. Weight loss surgeries, especially Roux-en-Y laparoscopic gastric bypass (LRYGB) and laparoscopic sleeve gastrectomy (LSG), reduce this risk. Our meta-analysis addresses the varying post-surgery outcomes and research gaps from prior studies.
LRYGB and LSG surgeries exhibit potential impacts on colorectal cancer, but current studies show inconsistencies. Our research aims to bridge these gaps, informing clinical choices, shaping policies, and directing future investigations.
To quantitatively analyze the link between obesity and colorectal cancer, assess the impact of LRYGB and LSG surgeries, discern gender-specific risks, and refine methodological approaches in meta-analyses.
We conducted a comprehensive search on PubMed, Embase, Web of Science, and Cochrane Library using terms including "obesity," "colorectal cancer," "gastric bypass," and "sleeve gastrectomy." We then assessed the retrieved articles based on the PRISMA-guided the Population, Intervention, Comparison, Outcome, and Study design framework: Population (adults with morbid obesity), Intervention (weight loss surgery), Comparison (observation or other treatments), Outcome (risk of colorectal cancer), and Study design (comparative studies with minimum ten patients/group).
Analyzing 17 studies with over 12 million patients, we found that bariatric surgery (BS) patients had a 54% reduced colorectal cancer risk. Subgroup insights showed a 46% risk reduction in females post-BS, while male trends were inconclusive. Specific surgical methods like sleeve gastrectomy and RYGB didn't show differential benefits. Rigorous hazard ratio and Newcastle-Ottawa Scale assessments validated our findings, with no detected publication bias. However, distinct outcomes for colon and rectal cancer remained unresolved.
Bariatric surgery notably lowers colorectal cancer risk, especially in females, irrespective of the surgical type. Our expansive meta-analysis, adhering to rigorous standards, offers a nuanced insight into this relationship.
Future studies should unravel the mechanisms behind bariatric surgery's protective effect, explore gut microbiota's role, compare surgery types, assess long-term impacts, and consider confounding factors.